When it comes to trials of any drug, size matters, potentially giving the World Health Organization's (WHO) gloomy verdict on Gilead Sciences' COVID-19 treatment remdesivir an edge over the company's ...
A row broke out on Friday over a World Health Organization (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patient's chances of surviving COVID-19 ...
Groundbreaking new tests reveal patterns in our immune systems that can signal underlying disease and tell us how well we ...
Researchers, funders, and industry experts in 2D materials call for science to reward reliability over speed, proposing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback